Immunotech Laboratories

IMMB · OTC

$0.0002+$0.00 (+0.00%)TodayMarket closed · Oct 19, 2:02 PM ET

No price history for this range.

About IMMB

Immunotech Laboratories, Inc. is a drug development company. The company is headquartered in Glendale, California and currently employs 4 full-time employees. The company went IPO on 2002-01-07. The firm is also focused on the commercialization of its proprietary proteins known as Irreversible Pepsin Fraction (IPF) ITV-1 for the treatment of debilitating infectious diseases, such as human immunodeficiency virus (HIV) and Hepatitis Type C.

Employees: 4
Headquarters: Glendale, California
Listed: Jan 7, 2002
Sector: Health Care
Industry: Biotechnology
Website: immunotechlab.com

Leadership

Immunotech Laboratories executives
Name	Title	Since	Age
Harry Zhabilov	—	2007	44
Roscoe Moore	—	—	—

Similar companies

Companies in the same industry as Immunotech Laboratories

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.